<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Cardiovascular risk of smoking and benefits of smoking cessation
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Cardiovascular risk of smoking and benefits of smoking cessation
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Cardiovascular risk of smoking and benefits of smoking cessation
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Elizabeth Jackson, MD, MPH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Christopher P Cannon, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Susan B Yeon, MD, JD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Nov 11, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The facts regarding the impact of cigarette smoking on the development of cardiovascular disease are well known to both the medical profession and the public [
         <a href="#rid1">
          1-5
         </a>
         ]. In spite of the extensive data and efforts to educate the public, many smokers do not believe that smoking is harmful for them (or for those around them via secondhand smoke exposure). As an example, in one study of 737 active smokers, over 60 percent of did not believe that they were at an increased risk for a myocardial infarction [
         <a href="#rid6">
          6
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1506.html" rel="external">
          "Overview of established risk factors for cardiovascular disease"
         </a>
         .)
        </p>
        <p>
         The relationship between smoking and cardiovascular disease, the effects of smoking on the atherosclerosis process, and the beneficial effects of smoking cessation will be reviewed here [
         <a href="#rid1">
          1,7
         </a>
         ]. The therapeutic approach to smoking cessation is presented separately. (See
         <a class="medical medical_review" href="/z/d/html/16634.html" rel="external">
          "Overview of smoking cessation management in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16635.html" rel="external">
          "Pharmacotherapy for smoking cessation in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6920.html" rel="external">
          "Behavioral approaches to smoking cessation"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1207289475">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
        </p>
        <p class="headingAnchor" id="H809677302">
         <span class="h2">
          Prevalence of smoking
         </span>
         <span class="headingEndMark">
          —
         </span>
         Globally, an estimated 933.1 million people smoke, the majority of whom are men. The majority of smokers reside in low-to-middle-income countries. As of 2017, an estimated 14 percent of adults ≥18 years of age (15.8 percent of men and 12.2 percent of women) in the United States smoke [
         <a href="#rid8">
          8
         </a>
         ]. In the United States, the majority of smokers start smoking before the age of 25 years. The number of new smokers under the age of 18 has decreased; however, the rate of new smokers among those age 18 to 25 has increased [
         <a href="#rid8">
          8,9
         </a>
         ]. An estimated 27 percent of high school students report consuming tobacco products, of which 5.9 percent report using smokeless tobacco [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          United States regional differences
         </strong>
         – Rates of smoking vary by region in the United States, with this highest number of current smokers residing in the Midwest (16.9 percent) and South (15.5 percent) [
         <a href="#rid11">
          11
         </a>
         ]. West Virginia has the highest prevalence of current smokers at 28 percent, while Utah has the lowest (8.8 percent).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Sex and race-ethnic differences
         </strong>
         – Smoking rates are higher among men and some Native American groups [
         <a href="#rid12">
          12
         </a>
         ] compared with other racial/ethnic groups. An estimated 15.2 percent of non-Hispanic White Americans report current smoking, while 14.9 percent of non-Hispanic Black Americans and 9.9 percent of Hispanic Americans report smoking [
         <a href="#rid11">
          11
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Socioeconomic status differences
         </strong>
         – Smoking rates are higher among those with lower education and income levels.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h2">
          Cigarette smoking and CVD
         </span>
         <span class="headingEndMark">
          —
         </span>
         With respect to cardiovascular disease (CVD), the following observations have been made regarding a major role for cigarette smoking:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Smoking is an independent major risk factor for total atherosclerotic CVD, coronary heart disease (CHD), cerebrovascular disease, heart failure, and all-cause mortality, with an apparent dose-dependent relationship [
         <a href="#rid13">
          13-17
         </a>
         ]. (See
         <a class="local">
          'Dose and duration of smoking exposure'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The incidence of myocardial infarction (MI) is increased sixfold in women and threefold in men who smoke at least 20 cigarettes per day, when compared with subjects who never smoked [
         <a href="#rid18">
          18,19
         </a>
         ]. In the worldwide INTERHEART study of patients from 52 countries, smoking accounted for 36 percent of the population-attributable risk of a first MI [
         <a href="#rid20">
          20
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1506.html" rel="external">
          "Overview of established risk factors for cardiovascular disease", section on 'Cigarette smoking'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a systematic review and meta-analysis of 75 cohorts that evaluated the risks of smoking on CHD and adjusted for the effects of other known CHD risk factors (over 2.4 million persons with over 44,000 CHD events), female smokers were 25 percent more likely than male smokers to develop CHD (relative risk ratio 1.25, 95% CI 1.12-1.39) [
         <a href="#rid21">
          21
         </a>
         ]. Female sex is also associated with more adverse events after acute coronary syndrome [
         <a href="#rid22">
          22
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Among a cohort of 4129 Black participants in the Jackson Heart Study without a history of heart failure who were followed for a median of eight years, there was a significantly higher risk of developing heart failure among current cigarette smokers (hazard ratio [HR] 2.8, 95% CI 1.7-4.6) and former smokers with greater than 15 pack-year history (HR 2.1, 95% CI 1.3-3.3) compared with those who never smoked [
         <a href="#rid16">
          16
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients who continue to smoke in the presence of established CHD have an increased risk of repeat MI and an increased risk of death, including sudden cardiac death [
         <a href="#rid23">
          23-26
         </a>
         ]. Among smokers who quit after MI, risk for recurrent events declines over time [
         <a href="#rid27">
          27
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients who continue to smoke following revascularization (either percutaneous coronary intervention or coronary artery bypass grafting) have significantly higher mortality compared with those who quit smoking. (See
         <a class="local">
          'Surgical revascularization'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Smokers are at high risk for peripheral arterial disease (PAD). Among a cohort of 22,203 patients with PAD, including 1995 patients who smoke, almost 50 percent of smokers were hospitalized over a one-year follow-up period, significantly higher than PAD patients who do not smoke [
         <a href="#rid28">
          28
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H6350311">
         <span class="h3">
          Dose and duration of smoking exposure
         </span>
         <span class="headingEndMark">
          —
         </span>
         The risk of CVD related to cigarette smoking is present for even very low doses (ie, number of cigarettes), with smokers who consume less than five cigarettes per day having an increased risk for CVD events such as acute MI. Smoking even one cigarette per day is associated with approximately 50 percent increased risk for CHD and approximately 25 percent increased risk for stroke [
         <a href="#rid29">
          29
         </a>
         ]. With increases in the number of cigarettes smoked per day, increased risk for CVD has been observed in several studies [
         <a href="#rid16">
          16,29-34
         </a>
         ]. As examples:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Data from the National Health Interview Survey from 329,035 United States adults observed a significant increase in all-cause mortality among those who smoked one to two cigarettes per day (HR 1.93, 95% CI 1.73-2.16) and three to five cigarettes per day (HR 1.99, 95% CI 1.83-2.17) compared with never smokers and after adjustment for demographic, clinical, and lifestyle factors [
         <a href="#rid35">
          35
         </a>
         ]. Death due to CVD was also increased for those smoking one to two cigarettes per day (HR 1.92, 95% CI 1.58-2.36) and three to five cigarettes per day (HR 1.96, 95% CI 1.63-2.35).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In the Pooling Project on Diet and Coronary Heart Disease study, which pooled data from eight prospective studies including 266,787 adults ages 40 to 89 years who were enrolled between 1974 and 1996 and followed for an average of up to eight years, current smokers who smoked 15 or more cigarettes per day had almost 2.5 times the risk of CHD compared with a non-smoker [
         <a href="#rid30">
          30
         </a>
         ]. For those who smoked less than 15 cigarettes per day, the risk of CHD was near double that of a non-smoker.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a case-control study using 27,089 participants from the INTERHEART study (12,461 cases with acute MI, 14,637 controls), there was a clear dose-response between the number of cigarettes smoked per day and risk for acute MI [
         <a href="#rid33">
          33
         </a>
         ]. The odds of having an MI was 1.056 for each additional cigarette smoked. The odds of an MI were ninefold higher among those who smoked 40 or more cigarettes per day compared with never-smokers.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In the US Veterans study, the risk for CHD among current smokers ranged from 1.24 for those who smoked &lt;10 cigarettes per day to 1.56 for those who smoked 10 to 20 cigarettes per day, and 1.76 for those who smoked between 20 and 40 cigarettes per day [
         <a href="#rid31">
          31
         </a>
         ]. The highest CHD risk of 1.94 was observed for those who smoked 40 or more cigarettes per day.
        </p>
        <p>
        </p>
        <p>
         The cumulative duration of smoking is also associated with risk for CHD events, with a longer duration and higher number of cigarettes yielding a greater risk. Increasing risk for CHD death was observed with increasing duration of smoking at every level of daily smoking (from 1 to 19 cigarettes per day to 40 or more cigarettes per day) [
         <a href="#rid36">
          36
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H279614327">
         <span class="h2">
          Cigarette smoking and atherosclerosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         The direct effect of smoking on the development of atherosclerosis has been documented in numerous studies, including studies of living patients using surrogate markers (ie, intima-medial thickness) and autopsy studies with direct pathologic demonstration of atherosclerotic plaques.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In the ARIC (Atherosclerosis Risk in Communities) study, which enrolled 10,914 patients and measured intima-medial thickness of the carotid artery by ultrasound over a three-year period, current smoking was associated with a 50 percent increase in the progression of atherosclerosis versus non-smokers [
         <a href="#rid37">
          37
         </a>
         ]. Additionally, patients with environmental tobacco smoke exposure (ie, secondhand smoke) had a 20 percent greater rate of atherosclerosis progression compared with patients without secondhand smoke exposure.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Several large autopsy studies have noted an association between cigarette smoking and atherosclerosis in the major coronary arteries [
         <a href="#rid38">
          38-42
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Using autopsy data from 93 children and young adults (age range from 2 to 39 years) enrolled in the Bogalusa Heart Study who had died principally from trauma and for whom data on risk factors were available, cigarette smoking increased the number of fatty streaks and fibrous plaques (the beginnings of atherosclerotic plaques) compared with non-smokers [
         <a href="#rid39">
          39
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study, a multicenter study that included trauma victims between the ages of 15 and 34 years and compared findings from coronary arteries in 50 smokers and 50 non-smokers, advanced atherosclerotic lesions were significantly more common among smokers compared with non-smokers (31 versus 14 percent), and the number of advanced atherosclerotic lesions was also greater in smokers [
         <a href="#rid40">
          40
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1723788905">
         <span class="h2">
          Non-cigarette smoking and CVD
         </span>
         <span class="headingEndMark">
          —
         </span>
         With respect to the risk of CVD associated with non-cigarette smoking (eg, pipe or cigar smoking, smokeless tobacco, etc), the data are somewhat less clear regarding the risks. Many studies have shown an increased CVD risk associated with pipe or cigar smoking, but others have not shown this increased CVD risk.
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h3">
          Cigar smoking
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although there is an established association between cigar smoking and cancer of the upper respiratory, lungs, and gastrointestinal tract and the risk of chronic obstructive lung disease, cigars are generally perceived as being safer than cigarettes. Moreover, data about the role of cigar smoking and the risk of cardiovascular disease are limited. Cigar smoke contains many of the same toxic and carcinogenic compounds that are found in cigarette smoke, and subjects who smoke four or more cigars per day are exposed to an amount of smoke equivalent to 10 cigarettes; even those who do not inhale are exposed to their own environmental smoke.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a cohort study of 17,774 men who were followed for 14 years, those who smoked cigars were at a greater risk for developing CHD (relative risk 1.3 compared with non-smokers); there was a dose-response relationship for those who smoked less than or greater than five cigars per day (relative risk 1.2 and 1.6, respectively) [
         <a href="#rid43">
          43
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a cohort study of 121,278 men ≥30 years of age, current cigar smokers ≤75 years of age had an increased risk of death from CHD (adjusted rate ratio 1.3), while there was no increased risk in those &gt;75 years of age or former cigar smokers of any age [
         <a href="#rid44">
          44
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H28118557">
         <span class="h3">
          Pipe smoking
         </span>
         <span class="headingEndMark">
          —
         </span>
         Data specifically related to the risk of CV events from pipe smoking are limited compared with the wealth of data available regarding cigarette smoking. Some studies suggest increased CVD risk compared with non-smokers, which is still lower than that of cigarette smokers, while others observed no increase in CVD risk [
         <a href="#rid31">
          31,45-47
         </a>
         ]. In total, however, the evidence seems to suggest pipe smoking increases the risk for CVD events [
         <a href="#rid36">
          36,46
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In early data derived from over 5000 participants in the Framingham Heart Study, the risks of MI and death due to heart disease were not significantly different between pipe and cigar smokers and non-smokers [
         <a href="#rid46">
          46
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Among a longitudinal cohort of 293,000 US veterans followed for 16 years, all-cause mortality for pure pipe smokers was increased compared with non-smokers [
         <a href="#rid31">
          31
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Among 16,932 Norwegian men ages 20 to 49 years who were screened in the mid-1970s and again between 3 to 13 years later, then followed through 2007, pipe smoking was associated with increased total mortality (adjusted RR 2.0, 95% CI 1.7-2.3) [
         <a href="#rid45">
          45
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Although study results have varied, differences in data collection regarding pipe smoking and combinations of pipe, cigar, and cigarette smoking in addition to variation in duration of follow-up may at least partially explain the heterogeneity. For the studies that suggest a lower CV risk related to pipe smoking (relative to cigarette smoking), reduced inhalation of smoke has been thought to be a reason for the lower risk [
         <a href="#rid36">
          36
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H639080596">
         <span class="h3">
          Secondhand smoke
         </span>
         <span class="headingEndMark">
          —
         </span>
         Exposure to secondhand smoke increases non-smokers' risk of cardiovascular disease. While the risk estimates for secondhand smoke and CHD outcomes vary, most studies show modest increases in risk. The impact of secondhand smoke on the cardiovascular system is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6919.html" rel="external">
          "Secondhand smoke exposure: Effects in adults", section on 'Cardiovascular disease and stroke'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h3">
          Smokeless tobacco
         </span>
         <span class="headingEndMark">
          —
         </span>
         The cardiovascular health hazards of smokeless tobacco are not well established, with mixed results in different studies [
         <a href="#rid48">
          48-51
         </a>
         ]. However, the evidence seems to suggest that the risk for CVD events is lower than the risk in smokers but higher than the risk in non-smokers.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In one case-control study of 687 men (ages 24 to 64 years) with a first-time MI and 687 matched controls, there was no significant difference in the incidence of MI between non-smoking regular snuff users and those who never used any tobacco products (adjusted odds ratio [OR] 0.96) [
         <a href="#rid49">
          49
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In contrast, in a much larger study of over 135,000 male construction industry employees from Sweden, including over 6000 smokeless tobacco users, the age-adjusted relative risk of cardiovascular mortality was 1.4 for smokeless tobacco users [
         <a href="#rid51">
          51
         </a>
         ]. For men aged 35 through 54 at the start of follow-up, the relative risk was 2.1.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Among a cohort of 2474 Swedish smokeless tobacco users treated for MI between 2005 and 2009 who were followed for an average of 2.1 years, patients who quit using snuff following their MI had a significant reduction in mortality compared with those who continued to use snuff (HR 0.55, 95% CI 0.21-0.99) [
         <a href="#rid50">
          50
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4029040174">
         <span class="h3">
          Electronic cigarettes
         </span>
         <span class="headingEndMark">
          —
         </span>
         Data on the relationship between electronic cigarette (e-cigarette) use and its impact on CVD outcomes are scarce. However, of concern are the rates of new smokers who report initially starting e-cigarette use before starting to smoke cigarettes [
         <a href="#rid8">
          8
         </a>
         ]. Furthermore, in a study of 449,092 participants, those who reported the dual use of e-cigarettes and combustible traditional cigarettes had a higher odds for CVD (OR 1.36; 95% CI, 1.18-1.56) compared with those who reported smoking combustible cigarettes alone [
         <a href="#rid52">
          52
         </a>
         ]. No increased risk for CVD was noted among those who used only e-cigarettes. E-cigarettes are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/98400.html" rel="external">
          "Vaping and e-cigarettes"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h1">
          PATHOGENESIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although the relationship between coronary heart disease (CHD) and smoking, even when passive, appears clear, the mechanism by which it occurs is incompletely understood. Multiple factors are likely involved since smoking has a variety of effects that may contribute to atherogenesis [
         <a href="#rid1">
          1,53
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Smoking is associated with an adverse effect on serum lipids (elevated low-density lipoproteins and triglycerides and reduced high-density lipoproteins) and with insulin resistance [
         <a href="#rid54">
          54-56
         </a>
         ]. In addition, free radicals in cigarette smoke damage lipids, resulting in the formation of proatherogenic oxidized particles, specifically oxidized low-density lipoprotein cholesterol [
         <a href="#rid57">
          57-59
         </a>
         ]. A similar effect is seen with acute secondhand smoke exposure [
         <a href="#rid60">
          60
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4565.html" rel="external">
          "Lipoprotein classification, metabolism, and role in atherosclerosis", section on 'Lipoproteins and atherosclerosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cigarette smoking activates the sympathetic nervous system, producing an increase in heart rate and blood pressure, and cutaneous and perhaps coronary vasoconstriction [
         <a href="#rid5">
          5,61-63
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cigarette smoke contains carbon monoxide, which when inhaled results in higher levels of carboxyhemoglobin. This does not appear to directly cause atherosclerosis or cardiovascular disease (CVD), but may have adverse effects for patients with established CVD. (See
         <a class="local">
          'Role of carbon monoxide'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Smoking is associated with increased inflammation (as measured by C-reactive protein) and enhances the prothrombotic state via inhibition of tissue plasminogen activator release from the endothelium, elevation in the blood fibrinogen concentration, increased platelet activity (possibly due to enhanced sympathetic activity), increased expression of tissue factor, and, in patients with advanced lung disease, elevated whole blood viscosity due to secondary polycythemia [
         <a href="#rid5">
          5,64-70
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1484.html" rel="external">
          "C-reactive protein in cardiovascular disease", section on 'Possible pathogenic role of CRP'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Smoking can damage the vascular wall, possibly leading to impaired prostacyclin production and enhanced platelet-vessel wall interactions [
         <a href="#rid71">
          71
         </a>
         ]. This can reduce the elastic properties of the aorta, resulting in stiffening of and trauma to the wall [
         <a href="#rid72">
          72
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Smoking, as well as passive exposure to smoke, impairs endothelium-dependent vasodilation of normal coronary arteries and reduces coronary flow reserve [
         <a href="#rid73">
          73-78
         </a>
         ]. Smoking can also potentiate the endothelial dysfunction induced by hypercholesterolemia [
         <a href="#rid58">
          58,75
         </a>
         ]. The effect on endothelial function results from oxidative stress with enhanced oxidation of LDL and from reduced generation of nitric oxide [
         <a href="#rid68">
          68,74,77,79,80
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Smoking, in addition to narrowing the lumen of epicardial coronary arteries and larger arterioles, causes microvascular constriction through a variety of biochemical, physiological, and metabolic factors [
         <a href="#rid81">
          81
         </a>
         ]. Changes in endothelial and platelet function, and the adrenergic nervous system, in addition to changes in metabolic vasoregulation, may contribute to smoking-induced alterations in the coronary microcirculation and result in angina and/or cardiac dysfunction.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Smoking has been correlated with elevations in serum homocysteine, which is thought to induce vascular injury by multiple mechanisms [
         <a href="#rid69">
          69
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6837.html" rel="external">
          "Overview of homocysteine"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="9698" href="/z/d/drug information/9698.html" rel="external">
          Nicotine
         </a>
         in cigarette smoke plays a major role in the transient smoking-related increases in cardiac output, heart rate, and blood pressure. However, it is not clear if nicotine plays a direct role in the development of atherosclerosis [
         <a href="#rid82">
          82-85
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1517.html" rel="external">
          "Cardiovascular effects of nicotine"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Role of carbon monoxide
         </span>
         <span class="headingEndMark">
          —
         </span>
         Carbon monoxide is inhaled in cigarette smoke. It binds more avidly than oxygen to hemoglobin, reducing the amount of hemoglobin available to carry oxygen and impeding oxygen release by hemoglobin that is not directly bound to carbon monoxide. This effect can be detected clinically by measuring carboxyhemoglobin levels, which average 5 to 10 percent higher in smokers than non-smokers, in whom levels are less than 1 percent [
         <a href="#rid86">
          86
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/105477.html" rel="external">
          "Inhalation injury from heat, smoke, or chemical irritants"
         </a>
         .)
        </p>
        <p>
         In healthy subjects, carbon monoxide administration, under conditions similar to cigarette smoking, does not affect blood pressure, plasma catecholamines, platelet aggregation, or serum C-reactive protein [
         <a href="#rid87">
          87
         </a>
         ]. Since these parameters are changed with smoking, the observations suggest that some factor other than carbon monoxide is responsible. By comparison, carbon monoxide exposure in patients with CHD results in severe adverse effects. These include exercise-induced ischemia at a lower level of work, ventricular dysfunction, and increased number and complexity of ventricular arrhythmias [
         <a href="#rid88">
          88,89
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h1">
          SMOKING AND OUTCOMES AFTER REPERFUSION THERAPIES
         </span>
         <span class="headingEndMark">
          —
         </span>
         The relative outcomes of smokers compared with non-smokers following reperfusion therapies have been evaluated across the spectrum of presentations of coronary heart disease.
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h2">
          After fibrinolytic therapy for STEMI
         </span>
         <span class="headingEndMark">
          —
         </span>
         Despite the important role of cigarette smoking in the development of atherosclerosis, several studies have reported that smokers who receive a fibrinolytic agent for an acute myocardial infarction (MI) have a
         <strong>
          better
         </strong>
         outcome than non-smokers [
         <a href="#rid90">
          90-97
         </a>
         ]. This phenomenon is called the "smoker's paradox." (See
         <a class="medical medical_review" href="/z/d/html/55.html" rel="external">
          "Acute ST-elevation myocardial infarction: The use of fibrinolytic therapy"
         </a>
         .)
        </p>
        <p>
         As an example, GUSTO I, the largest trial to evaluate the impact of cigarette smoking on outcomes, included 11,975 non-smokers, 11,117 ex-smokers, and 17,507 current smokers [
         <a href="#rid92">
          92
         </a>
         ]. Non-smokers had a significantly higher in-hospital mortality (9.9 versus 3.7) and 30 day mortality (10.3 versus 4.0 percent).
        </p>
        <p>
         The reason for the paradoxically better outcomes after fibrinolysis in smokers may be related to the following factors:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Smokers have a higher hematocrit and baseline level of fibrinogen, suggesting a hypercoagulable state [
         <a href="#rid93">
          93,94
         </a>
         ]. More active thrombogenic mechanisms may lead to a larger thrombus component that is more susceptible to fibrinolytic therapy, resulting in smokers having a higher patency rate and being more likely to have TIMI-3 flow in the infarct artery after fibrinolysis [
         <a href="#rid93">
          93,94,98
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Smokers have an otherwise better risk profile than non-smokers; they tend to be significantly younger (mean 11 years in GUSTO I) and have a lower incidence of diabetes, hypertension, previous infarction, and severe coronary disease than non-smokers [
         <a href="#rid90">
          90-97
         </a>
         ]. Also, for unclear reasons, smokers are more likely to have an inferior rather than anterior wall infarction [
         <a href="#rid93">
          93,94,97
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         After adjustment for these clinical factors, some but not all studies reported that smoking history was of not an independent prognostic factor [
         <a href="#rid92">
          92,93,95,97
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h2">
          After revascularization with PCI or CABG
         </span>
         <span class="headingEndMark">
          —
         </span>
         In contrast to the smoker’s paradox identified among patients receiving thrombolytic therapy for STEMI, patients who smoke and undergo revascularization with either percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) appear to have worse outcomes compared with non-smokers [
         <a href="#rid99">
          99,100
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Among 6519 patients from three cohorts (EPIC, EPILOG, and EPISTENT), including 34 percent who smoked, smokers were more likely to experience death, MI, or urgent revascularization within 30 days following their initial PCI (adjusted OR 1.22, 95% CI 1.02-1.47) [
         <a href="#rid100">
          100
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Among patients in the SYNTAX trial comparing PCI with drug-eluting stents and CABG, smoking was an independent predictor of death, MI, or stroke (HR 1.8, 95% CI 1.3-2.5) [
         <a href="#rid99">
          99
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h1">
          CARDIOVASCULAR BENEFITS OF SMOKING CESSATION
         </span>
        </p>
        <p class="headingAnchor" id="H3360382374">
         <span class="h2">
          Overall cardiovascular benefits
         </span>
         <span class="headingEndMark">
          —
         </span>
         The benefits of quitting cigarette smoking (and tobacco use of any variety) are firmly established but perhaps less well known and accepted amongst the general public. Among subjects without known coronary heart disease (CHD), the reduction in cardiac event rate associated with smoking cessation ranges from 7 to 47 percent [
         <a href="#rid101">
          101-104
         </a>
         ]. The cardiac risks associated with cigarette smoking diminish within a few years after smoking cessation and continue to fall with increasing length of time since quitting. Among 8770 participants in the original and offspring portions of the Framingham Heart Study, including 5308 "ever" smokers who were followed for a median of 26.4 years, the risk of a major adverse cardiovascular event (MACE; includes cardiovascular disease [CVD] death, MI, stroke, or heart failure) was significantly lower within five years of quitting smoking (HR 0.61; 95% CI 0.49-0.76 compared to active smokers) [
         <a href="#rid105">
          105
         </a>
         ]. However, it takes at least 10, and perhaps as long as 15, years for MACE incidence rates of former smokers to approach those of "never" smokers [
         <a href="#rid105">
          105
         </a>
         ]. More intensive smoking cessation efforts have been shown to be more successful in achieving sustained abstinence and lowering future cardiovascular disease (CVD) risks [
         <a href="#rid106">
          106
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/16706.html" rel="external">
          "Benefits and consequences of smoking cessation"
         </a>
         .)
        </p>
        <p>
         Despite these facts, significant proportions of the adult population worldwide continue to smoke, and there has been little change in the prevalence of smoking since 1990 [
         <a href="#rid107">
          107
         </a>
         ]. In both sexes, smoking rates are higher in less educated and poorer segments of the population. Approximately 70 percent of cigarette smokers state that they would like to quit smoking. (See
         <a class="local">
          'Introduction'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H2632818576">
         <span class="h2">
          Impact of public smoking bans
         </span>
         <span class="headingEndMark">
          —
         </span>
         Changes in public policy have resulted in smoking bans in many communities, with subsequent research on the effects of smoking using communities as their own controls (ie, comparing disease rates before and after smoking bans). In a meta-analysis including 11 studies published between 2004 and 2009 that included data on acute myocardial infarction (MI) rates and data on smoking bans, smoking bans were associated with a 17 percent decrease in acute MI risk (incident rate ratio 0.83, 95% CI, 0.75-0.92) [
         <a href="#rid108">
          108
         </a>
         ]. Reductions in hospital admissions for smoking-related diseases, including CHD, have also been reported following smoking bans, with the greatest reduction in hospital admissions noted for CHD admissions, which were reduced by 39 percent after one year and 47 percent by three years post implementation [
         <a href="#rid109">
          109
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h2">
          Acute coronary syndromes
         </span>
         <span class="headingEndMark">
          —
         </span>
         Smoking cessation improves outcomes in patients who have had an acute coronary syndrome [
         <a href="#rid24">
          24,25,27,106,110,111
         </a>
         ]. In a meta-analysis of 20 prospective cohort studies (including patients with an MI, coronary artery bypass graft surgery [CABG], percutaneous coronary intervention [PCI], or known stable CHD and at least two years follow-up), which included 12,603 smokers, of whom 5659 ceased smoking and 6944 continued to smoke, the relative risk of mortality for smokers who quit compared with those who continued to smoke was 0.64 (95% CI 0.58-0.71). The benefit was not affected by age, sex, index cardiac event, country, or the year in which the study began [
         <a href="#rid110">
          110
         </a>
         ]. Observations from the 1995 to 2015 Coronary Artery Risk Development in Young Adults (CARDIA) study showed a 46 percent reduction in the risk of incident CVD in participants living in areas with workplace smoke-free policies compared to those who resided in areas without such policies [
         <a href="#rid112">
          112
         </a>
         ].
        </p>
        <p>
         Health-related quality of life has been shown to improve significantly among patients who quit smoking after an acute MI [
         <a href="#rid113">
          113
         </a>
         ]. Using data from two large US registries, smokers who did not quit had worse health-related quality of life metrics as compared with those who quit and never smokers.
        </p>
        <p class="headingAnchor" id="H139401134">
         <span class="h2">
          Surgical revascularization
         </span>
         <span class="headingEndMark">
          —
         </span>
         Smoking status following coronary revascularization, either coronary artery bypass graft (CABG) surgery or percutaneous coronary intervention (PCI), directly affects mortality.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Persistent smokers after CABG have a greater relative risk of all-cause mortality (relative risk 1.7), cardiac death (relative risk 1.8), and need for repeat revascularization (relative risk 1.4) compared with those who stopped smoking for at least one year [
         <a href="#rid114">
          114
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1554.html" rel="external">
          "Coronary artery bypass graft surgery: Graft choices"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Persistent smokers after PCI have a greater relative risk of death (1.8) and Q wave MI (2.1) compared with non-smokers, and a higher relative risk of total and cardiac mortality (relative risk 1.4 and 1.5, respectively) when compared with those who quit smoking [
         <a href="#rid115">
          115
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H5055694">
         <span class="h2">
          Sudden cardiac death
         </span>
         <span class="headingEndMark">
          —
         </span>
         In Olmsted County, Minnesota, a community that instituted a smoke-free workplace law, the incidence of MI declined by 33 percent, and the incidence of sudden cardiac death declined by 17 percent (109.1 to 92.0 per 100,000 population) in the 18 months following implementation of the smoke-free workplace law compared with the 18 months before the law [
         <a href="#rid104">
          104
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6919.html" rel="external">
          "Secondhand smoke exposure: Effects in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6376.html" rel="external">
          "Control of secondhand smoke exposure", section on 'Public smoking bans'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h2">
          Stroke
         </span>
         <span class="headingEndMark">
          —
         </span>
         The risk of ischemic stroke also decreases over time after smoking cessation. In one series of middle-aged women, the excess risk among former smokers largely disappeared two to four years after cessation [
         <a href="#rid116">
          116
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1120.html" rel="external">
          "Overview of secondary prevention of ischemic stroke", section on 'Smoking cessation'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h2">
          Effect of age
         </span>
         <span class="headingEndMark">
          —
         </span>
         The relative benefits of smoking cessation are equivalent in young and old patients [
         <a href="#rid110">
          110,111
         </a>
         ]. In one study of 1893 patients with CHD who were older than 55 years, the mortality after six-year follow-up was significantly higher among patients who continued to smoke compared with those who stopped (relative risk 1.7) [
         <a href="#rid111">
          111
         </a>
         ]. The benefits were equivalent in those ages 55 to 64 and over age 65 and were the same as observed among comparable patients aged 34 to 54.
        </p>
        <p class="headingAnchor" id="H84151498">
         <span class="h2">
          Improvement in endothelial function
         </span>
         <span class="headingEndMark">
          —
         </span>
         As mentioned above, smoking impairs endothelium-dependent vasodilation of normal coronary arteries and reduces coronary flow reserve [
         <a href="#rid73">
          73,76
         </a>
         ]. The impact of smoking cessation on endothelial function was studied prospectively in over 1500 smokers; after one year, 36 percent had successfully quit smoking [
         <a href="#rid78">
          78
         </a>
         ]. Despite gaining an average of 5 kg, smokers who quit had significantly improved endothelial function compared with baseline, while endothelial function did not improve from baseline in those who continued to smoke. This improvement in endothelial function likely contributes to the reduction in mortality and other benefits associated with smoking cessation.
        </p>
        <p class="headingAnchor" id="H22">
         <span class="h2">
          Methods of smoking cessation
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are a number of ways that clinicians can and should actively intervene against smoking in virtually all smokers  (
         <a class="graphic graphic_table graphicRef74402" href="/z/d/graphic/74402.html" rel="external">
          table 1
         </a>
         ). Behavioral therapy,
         <a class="drug drug_general" data-topicid="9698" href="/z/d/drug information/9698.html" rel="external">
          nicotine
         </a>
         replacement therapy, and the use of certain medications may each improve the quit rate. The approach to smoking cessation along with the available therapeutic options are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/16634.html" rel="external">
          "Overview of smoking cessation management in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16635.html" rel="external">
          "Pharmacotherapy for smoking cessation in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6920.html" rel="external">
          "Behavioral approaches to smoking cessation"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H783774628">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/111343.html" rel="external">
          "Society guideline links: Primary prevention of cardiovascular disease"
         </a>
         and
         <a class="medical medical_society_guidelines" href="/z/d/html/115645.html" rel="external">
          "Society guideline links: Secondary prevention of cardiovascular disease"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H23">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (see
         <a class="medical medical_basics" href="/z/d/html/15429.html" rel="external">
          "Patient education: Quitting smoking (The Basics)"
         </a>
         and
         <a class="medical medical_basics" href="/z/d/html/16327.html" rel="external">
          "Patient education: Heart attack recovery (The Basics)"
         </a>
         and
         <a class="medical medical_basics" href="/z/d/html/16429.html" rel="external">
          "Patient education: Recovery after coronary artery bypass graft surgery (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topics (see
         <a class="medical medical_patient" href="/z/d/html/2729.html" rel="external">
          "Patient education: Quitting smoking (Beyond the Basics)"
         </a>
         and
         <a class="medical medical_patient" href="/z/d/html/3430.html" rel="external">
          "Patient education: Heart attack recovery (Beyond the Basics)"
         </a>
         and
         <a class="medical medical_patient" href="/z/d/html/3432.html" rel="external">
          "Patient education: Recovery after coronary artery bypass graft surgery (CABG) (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H24">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Smoking as primary CVD risk factor
         </strong>
         – Smoking is a leading preventable primary risk factor for cardiovascular disease (CVD); is an independent major risk factor for total atherosclerotic CVD, coronary heart disease (CHD), cerebrovascular disease, and all-cause mortality; and has an apparent dose-dependent relationship with CVD outcomes. (See
         <a class="local">
          'Cigarette smoking and CVD'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Smoking as a secondary CVD risk factor
         </strong>
         – Among patients with established CVD, the risk of a recurrent event is increased among those who continue to smoke, compared with those who do not. (See
         <a class="local">
          'Cigarette smoking and CVD'
         </a>
         above and
         <a class="local">
          'Smoking and outcomes after reperfusion therapies'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Non-cigarette smoking
         </strong>
         – With respect to the risk of CVD associated with non-cigarette smoking (eg, pipe or cigar smoking, smokeless tobacco, etc), the data are somewhat less clear regarding the risks. Many studies have shown an increased CVD risk associated with pipe or cigar smoking, but others have not shown this increased CVD risk. Exposure to secondhand smoke increases non-smokers' risk of cardiovascular disease. (See
         <a class="local">
          'Non-cigarette smoking and CVD'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Benefits of smoking cessation
         </strong>
         – The benefits of quitting cigarette smoking (and tobacco use of any variety) are firmly established but perhaps less well known and accepted amongst the general public. The cardiac risks associated with cigarette smoking diminish with a few years after smoking cessation and continue to fall with increasing length of time since quitting. (See
         <a class="local">
          'Cardiovascular benefits of smoking cessation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p>
         <strong>
          ACKNOWLEDGMENT
         </strong>
         — The editorial staff at UpToDate acknowledge Geoffrey Barnes, MD, MSc, who contributed to an earlier version of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 2004; 43:1731.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           AHA, ACC, National Heart, Lung, and Blood Institute, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol 2006; 47:2130.
          </a>
         </li>
         <li class="breakAll">
          AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update A Guideline From the American Heart Association and American College of Cardiology Foundation http://circ.ahajournals.
         </li>
         <li class="breakAll">
          Value of Primordial and Primary Prevention for Cardiovascular Disease. A Policy Statement From the American Heart Association http://circ.ahajournals.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raghuveer G, White DA, Hayman LL, et al. Cardiovascular Consequences of Childhood Secondhand Tobacco Smoke Exposure: Prevailing Evidence, Burden, and Racial and Socioeconomic Disparities: A Scientific Statement From the American Heart Association. Circulation 2016; 134:e336.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ayanian JZ, Cleary PD. Perceived risks of heart disease and cancer among cigarette smokers. JAMA 1999; 281:1019.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith SC Jr, Benjamin EJ, Bonow RO, et al. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation 2011; 124:2458.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Virani SS, Alonso A, Benjamin EJ, et al. Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association. Circulation 2020; 141:e139.
          </a>
         </li>
         <li class="breakAll">
          Center for Behavioral Statistics and Quality. 2017 National Survey on Drug Use and Health: Detailed Tables. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2018.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gentzke AS, Creamer M, Cullen KA, et al. Vital Signs: Tobacco Product Use Among Middle and High School Students - United States, 2011-2018. MMWR Morb Mortal Wkly Rep 2019; 68:157.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang TW, Asman K, Gentzke AS, et al. Tobacco Product Use Among Adults - United States, 2017. MMWR Morb Mortal Wkly Rep 2018; 67:1225.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Breathett K, Sims M, Gross M, et al. Cardiovascular Health in American Indians and Alaska Natives: A Scientific Statement From the American Heart Association. Circulation 2020; 141:e948.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jee SH, Suh I, Kim IS, Appel LJ. Smoking and atherosclerotic cardiovascular disease in men with low levels of serum cholesterol: the Korea Medical Insurance Corporation Study. JAMA 1999; 282:2149.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Qiao Q, Tervahauta M, Nissinen A, Tuomilehto J. Mortality from all causes and from coronary heart disease related to smoking and changes in smoking during a 35-year follow-up of middle-aged Finnish men. Eur Heart J 2000; 21:1621.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Foody JM, Cole CR, Blackstone EH, Lauer MS. A propensity analysis of cigarette smoking and mortality with consideration of the effects of alcohol. Am J Cardiol 2001; 87:706.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kamimura D, Cain LR, Mentz RJ, et al. Cigarette Smoking and Incident Heart Failure: Insights From the Jackson Heart Study. Circulation 2018; 137:2572.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Benjamin EJ, Muntner P, Alonso A, et al. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation 2019; 139:e56.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Njølstad I, Arnesen E, Lund-Larsen PG. Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. A 12-year follow-up of the Finnmark Study. Circulation 1996; 93:450.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prescott E, Hippe M, Schnohr P, et al. Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ 1998; 316:1043.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364:937.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huxley RR, Woodward M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet 2011; 378:1297.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Howe M, Leidal A, Montgomery D, Jackson E. Role of cigarette smoking and gender in acute coronary syndrome events. Am J Cardiol 2011; 108:1382.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tofler GH, Muller JE, Stone PH, et al. Comparison of long-term outcome after acute myocardial infarction in patients never graduated from high school with that in more educated patients. Multicenter Investigation of the Limitation of Infarct Size (MILIS). Am J Cardiol 1993; 71:1031.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goldenberg I, Jonas M, Tenenbaum A, et al. Current smoking, smoking cessation, and the risk of sudden cardiac death in patients with coronary artery disease. Arch Intern Med 2003; 163:2301.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilson K, Gibson N, Willan A, Cook D. Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies. Arch Intern Med 2000; 160:939.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Suskin N, Sheth T, Negassa A, Yusuf S. Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction. J Am Coll Cardiol 2001; 37:1677.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rea TD, Heckbert SR, Kaplan RC, et al. Smoking status and risk for recurrent coronary events after myocardial infarction. Ann Intern Med 2002; 137:494.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Duval S, Long KH, Roy SS, et al. The Contribution of Tobacco Use to High Health Care Utilization and Medical Costs in Peripheral Artery Disease: A State-Based Cohort Analysis. J Am Coll Cardiol 2015; 66:1566.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hackshaw A, Morris JK, Boniface S, et al. Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports. BMJ 2018; 360:j5855.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tolstrup JS, Hvidtfeldt UA, Flachs EM, et al. Smoking and risk of coronary heart disease in younger, middle-aged, and older adults. Am J Public Health 2014; 104:96.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rogot E, Murray JL. Smoking and causes of death among U.S. veterans: 16 years of observation. Public Health Rep 1980; 95:213.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004; 328:1519.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Teo KK, Ounpuu S, Hawken S, et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 2006; 368:647.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Law MR, Wald NJ. Environmental tobacco smoke and ischemic heart disease. Prog Cardiovasc Dis 2003; 46:31.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Qin W, Magnussen CG, Li S, et al. Light Cigarette Smoking Increases Risk of All-Cause and Cause-Specific Mortality: Findings from the NHIS Cohort Study. Int J Environ Res Public Health 2020; 17.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Burns DM. Epidemiology of smoking-induced cardiovascular disease. Prog Cardiovasc Dis 2003; 46:11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Howard G, Wagenknecht LE, Burke GL, et al. Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study. JAMA 1998; 279:119.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Strong JP, Richards ML. Cigarette smoking and atherosclerosis in autopsied men. Atherosclerosis 1976; 23:451.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berenson GS, Srinivasan SR, Bao W, et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998; 338:1650.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zieske AW, Takei H, Fallon KB, Strong JP. Smoking and atherosclerosis in youth. Atherosclerosis 1999; 144:403.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Inoue T, Oku K, Kimoto K, et al. Relationship of cigarette smoking to the severity of coronary and thoracic aortic atherosclerosis. Cardiology 1995; 86:374.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Howard G, Burke GL, Szklo M, et al. Active and passive smoking are associated with increased carotid wall thickness. The Atherosclerosis Risk in Communities Study. Arch Intern Med 1994; 154:1277.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Iribarren C, Tekawa IS, Sidney S, Friedman GD. Effect of cigar smoking on the risk of cardiovascular disease, chronic obstructive pulmonary disease, and cancer in men. N Engl J Med 1999; 340:1773.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jacobs EJ, Thun MJ, Apicella LF. Cigar smoking and death from coronary heart disease in a prospective study of US men. Arch Intern Med 1999; 159:2413.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tverdal A, Bjartveit K. Health consequences of pipe versus cigarette smoking. Tob Control 2011; 20:123.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Castelli WP. Epidemiology of coronary heart disease: the Framingham study. Am J Med 1984; 76:4.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wannamethee SG, Lowe GD, Shaper AG, et al. Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J 2005; 26:1765.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gupta R, Gurm H, Bartholomew JR. Smokeless tobacco and cardiovascular risk. Arch Intern Med 2004; 164:1845.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huhtasaari F, Lundberg V, Eliasson M, et al. Smokeless tobacco as a possible risk factor for myocardial infarction: a population-based study in middle-aged men. J Am Coll Cardiol 1999; 34:1784.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arefalk G, Hambraeus K, Lind L, et al. Discontinuation of smokeless tobacco and mortality risk after myocardial infarction. Circulation 2014; 130:325.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bolinder G, Alfredsson L, Englund A, de Faire U. Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers. Am J Public Health 1994; 84:399.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Osei AD, Mirbolouk M, Orimoloye OA, et al. Association Between E-Cigarette Use and Cardiovascular Disease Among Never and Current Combustible-Cigarette Smokers. Am J Med 2019; 132:949.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leone A, Landini L. Vascular pathology from smoking: look at the microcirculation! Curr Vasc Pharmacol 2013; 11:524.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ 1989; 298:784.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Facchini FS, Hollenbeck CB, Jeppesen J, et al. Insulin resistance and cigarette smoking. Lancet 1992; 339:1128.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reaven G, Tsao PS. Insulin resistance and compensatory hyperinsulinemia: the key player between cigarette smoking and cardiovascular disease? J Am Coll Cardiol 2003; 41:1044.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miller ER 3rd, Appel LJ, Jiang L, Risby TH. Association between cigarette smoking and lipid peroxidation in a controlled feeding study. Circulation 1997; 96:1097.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heitzer T, Ylä-Herttuala S, Luoma J, et al. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation 1996; 93:1346.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pech-Amsellem MA, Myara I, Storogenko M, et al. Enhanced modifications of low-density lipoproteins (LDL) by endothelial cells from smokers: a possible mechanism of smoking-related atherosclerosis. Cardiovasc Res 1996; 31:975.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Valkonen M, Kuusi T. Passive smoking induces atherogenic changes in low-density lipoprotein. Circulation 1998; 97:2012.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cryer PE, Haymond MW, Santiago JV, Shah SD. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med 1976; 295:573.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Winniford MD, Wheelan KR, Kremers MS, et al. Smoking-induced coronary vasoconstriction in patients with atherosclerotic coronary artery disease: evidence for adrenergically mediated alterations in coronary artery tone. Circulation 1986; 73:662.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Narkiewicz K, van de Borne PJ, Hausberg M, et al. Cigarette smoking increases sympathetic outflow in humans. Circulation 1998; 98:528.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Newby DE, Wright RA, Labinjoh C, et al. Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction. Circulation 1999; 99:1411.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kannel WB, D'Agostino RB, Belanger AJ. Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study. Am Heart J 1987; 113:1006.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fusegawa Y, Goto S, Handa S, et al. Platelet spontaneous aggregation in platelet-rich plasma is increased in habitual smokers. Thromb Res 1999; 93:271.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Matetzky S, Tani S, Kangavari S, et al. Smoking increases tissue factor expression in atherosclerotic plaques: implications for plaque thrombogenicity. Circulation 2000; 102:602.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mazzone A, Cusa C, Mazzucchelli I, et al. Cigarette smoking and hypertension influence nitric oxide release and plasma levels of adhesion molecules. Clin Chem Lab Med 2001; 39:822.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bazzano LA, He J, Muntner P, et al. Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Intern Med 2003; 138:891.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bermudez EA, Rifai N, Buring JE, et al. Relation between markers of systemic vascular inflammation and smoking in women. Am J Cardiol 2002; 89:1117.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nowak J, Murray JJ, Oates JA, FitzGerald GA. Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes. Circulation 1987; 76:6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stefanadis C, Tsiamis E, Vlachopoulos C, et al. Unfavorable effect of smoking on the elastic properties of the human aorta. Circulation 1997; 95:31.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Celermajer DS, Sorensen KE, Georgakopoulos D, et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993; 88:2149.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barua RS, Ambrose JA, Eales-Reynolds LJ, et al. Dysfunctional endothelial nitric oxide biosynthesis in healthy smokers with impaired endothelium-dependent vasodilatation. Circulation 2001; 104:1905.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sumida H, Watanabe H, Kugiyama K, et al. Does passive smoking impair endothelium-dependent coronary artery dilation in women? J Am Coll Cardiol 1998; 31:811.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Celermajer DS, Adams MR, Clarkson P, et al. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med 1996; 334:150.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaufmann PA, Gnecchi-Ruscone T, di Terlizzi M, et al. Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function. Circulation 2000; 102:1233.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Johnson HM, Gossett LK, Piper ME, et al. Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial. J Am Coll Cardiol 2010; 55:1988.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kugiyama K, Yasue H, Ohgushi M, et al. Deficiency in nitric oxide bioactivity in epicardial coronary arteries of cigarette smokers. J Am Coll Cardiol 1996; 28:1161.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ichiki K, Ikeda H, Haramaki N, et al. Long-term smoking impairs platelet-derived nitric oxide release. Circulation 1996; 94:3109.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rooks C, Faber T, Votaw J, et al. Effects of smoking on coronary microcirculatory function: a twin study. Atherosclerosis 2011; 215:500.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mayhan WG, Sharpe GM. Chronic exposure to nicotine alters endothelium-dependent arteriolar dilatation: effect of superoxide dismutase. J Appl Physiol (1985) 1999; 86:1126.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li Z, Barrios V, Buchholz JN, et al. Chronic nicotine administration does not affect peripheral vascular reactivity in the rat. J Pharmacol Exp Ther 1994; 271:1135.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sun YP, Zhu BQ, Browne AE, et al. Nicotine does not influence arterial lipid deposits in rabbits exposed to second-hand smoke. Circulation 2001; 104:810.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Neunteufl T, Heher S, Kostner K, et al. Contribution of nicotine to acute endothelial dysfunction in long-term smokers. J Am Coll Cardiol 2002; 39:251.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Puente-Maestu L, Bahonza N, Pérez MC, et al. [Relationship between tobacco smoke exposure and the concentrations of carboxyhemoglobin and hemoglobin]. Arch Bronconeumol 1998; 34:339.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zevin S, Saunders S, Gourlay SG, et al. Cardiovascular effects of carbon monoxide and cigarette smoking. J Am Coll Cardiol 2001; 38:1633.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Allred EN, Bleecker ER, Chaitman BR, et al. Short-term effects of carbon monoxide exposure on the exercise performance of subjects with coronary artery disease. N Engl J Med 1989; 321:1426.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aronow WS, Cassidy J, Vangrow JS, et al. Effect of cigarette smoking and breathing carbon monoxide on cardiovascular hemodynamics in anginal patients. Circulation 1974; 50:340.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barbash GI, White HD, Modan M, et al. Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Circulation 1993; 87:53.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mueller HS, Cohen LS, Braunwald E, et al. Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II. Circulation 1992; 85:1254.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barbash GI, Reiner J, White HD, et al. Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 1995; 26:1222.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Burke AP, Farb A, Malcom GT, et al. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997; 336:1276.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gomez MA, Karagounis LA, Allen A, Anderson JL. Effect of cigarette smoking on coronary patency after thrombolytic therapy for myocardial infarction. TEAM-2 Investigators. Second Multicenter Thrombolytic Trials of Eminase in Acute Myocardial Infarction. Am J Cardiol 1993; 72:373.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gottlieb S, Boyko V, Zahger D, et al. Smoking and prognosis after acute myocardial infarction in the thrombolytic era (Israeli Thrombolytic National Survey). J Am Coll Cardiol 1996; 28:1506.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ishihara M, Sato H, Tateishi H, et al. Clinical implications of cigarette smoking in acute myocardial infarction: acute angiographic findings and long-term prognosis. Am Heart J 1997; 134:955.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ruiz-Bailén M, de Hoyos EA, Reina-Toral A, et al. Paradoxical effect of smoking in the Spanish population with acute myocardial infarction or unstable angina: results of the ARIAM Register. Chest 2004; 125:831.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Chillou C, Riff P, Sadoul N, et al. Influence of cigarette smoking on rate of reopening of the infarct-related coronary artery after myocardial infarction: a multivariate analysis. J Am Coll Cardiol 1996; 27:1662.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang YJ, Iqbal J, van Klaveren D, et al. Smoking is associated with adverse clinical outcomes in patients undergoing revascularization with PCI or CABG: the SYNTAX trial at 5-year follow-up. J Am Coll Cardiol 2015; 65:1107.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cho L, Bhatt DL, Wolski K, et al. Effect of smoking status and abciximab use on outcome after percutaneous coronary revascularization: Pooled analysis from EPIC, EPILOG, and EPISTENT. Am Heart J 2001; 141:599.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rose G, Hamilton PJ, Colwell L, Shipley MJ. A randomised controlled trial of anti-smoking advice: 10-year results. J Epidemiol Community Health 1982; 36:102.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group. JAMA 1982; 248:1465.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hjermann I, Velve Byre K, Holme I, Leren P. Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men. Lancet 1981; 2:1303.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hurt RD, Weston SA, Ebbert JO, et al. Myocardial infarction and sudden cardiac death in Olmsted County, Minnesota, before and after smoke-free workplace laws. Arch Intern Med 2012; 172:1635.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Duncan MS, Freiberg MS, Greevy RA Jr, et al. Association of Smoking Cessation With Subsequent Risk of Cardiovascular Disease. JAMA 2019; 322:642.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mohiuddin SM, Mooss AN, Hunter CB, et al. Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease. Chest 2007; 131:446.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ng M, Freeman MK, Fleming TD, et al. Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. JAMA 2014; 311:183.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meyers DG, Neuberger JS, He J. Cardiovascular effect of bans on smoking in public places: a systematic review and meta-analysis. J Am Coll Cardiol 2009; 54:1249.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khuder SA, Milz S, Jordan T, et al. The impact of a smoking ban on hospital admissions for coronary heart disease. Prev Med 2007; 45:3.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA 2003; 290:86.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hermanson B, Omenn GS, Kronmal RA, Gersh BJ. Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease. Results from the CASS registry. N Engl J Med 1988; 319:1365.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mayne SL, Widome R, Carroll AJ, et al. Longitudinal Associations of Smoke-Free Policies and Incident Cardiovascular Disease: CARDIA Study. Circulation 2018; 138:557.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buchanan DM, Arnold SV, Gosch KL, et al. Association of Smoking Status With Angina and Health-Related Quality of Life After Acute Myocardial Infarction. Circ Cardiovasc Qual Outcomes 2015; 8:493.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Domburg RT, Meeter K, van Berkel DF, et al. Smoking cessation reduces mortality after coronary artery bypass surgery: a 20-year follow-up study. J Am Coll Cardiol 2000; 36:878.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hasdai D, Garratt KN, Grill DE, et al. Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization. N Engl J Med 1997; 336:755.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kawachi I, Colditz GA, Stampfer MJ, et al. Smoking cessation and decreased risk of stroke in women. JAMA 1993; 269:232.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 1504 Version 44.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15145091" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : The pathophysiology of cigarette smoking and cardiovascular disease: an update.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16697342" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16697342" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16697342" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27619923" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Cardiovascular Consequences of Childhood Secondhand Tobacco Smoke Exposure: Prevailing Evidence, Burden, and Racial and Socioeconomic Disparities: A Scientific Statement From the American Heart Association.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10086437" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Perceived risks of heart disease and cancer among cigarette smokers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22052934" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31992061" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31992061" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30763302" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Vital Signs: Tobacco Product Use Among Middle and High School Students - United States, 2011-2018.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30408019" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Tobacco Product Use Among Adults - United States, 2017.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32460555" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Cardiovascular Health in American Indians and Alaska Natives: A Scientific Statement From the American Heart Association.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10591337" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Smoking and atherosclerotic cardiovascular disease in men with low levels of serum cholesterol: the Korea Medical Insurance Corporation Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10988015" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Mortality from all causes and from coronary heart disease related to smoking and changes in smoking during a 35-year follow-up of middle-aged Finnish men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11249887" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : A propensity analysis of cigarette smoking and mortality with consideration of the effects of alcohol.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29661945" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Cigarette Smoking and Incident Heart Failure: Insights From the Jackson Heart Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30700139" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8565161" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. A 12-year follow-up of the Finnmark Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9552903" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Smoking and risk of myocardial infarction in women and men: longitudinal population study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15364185" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21839503" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21924390" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Role of cigarette smoking and gender in acute coronary syndrome events.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8475864" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Comparison of long-term outcome after acute myocardial infarction in patients never graduated from high school with that in more educated patients. Multicenter Investigation of the Limitation of Infarct Size (MILIS).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14581249" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Current smoking, smoking cessation, and the risk of sudden cardiac death in patients with coronary artery disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10761958" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11345383" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12230350" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Smoking status and risk for recurrent coronary events after myocardial infarction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26429081" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : The Contribution of Tobacco Use to High Health Care Utilization and Medical Costs in Peripheral Artery Disease: A State-Based Cohort Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29367388" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23763425" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Smoking and risk of coronary heart disease in younger, middle-aged, and older adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7384406" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Smoking and causes of death among U.S. veterans: 16 years of observation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15213107" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Mortality in relation to smoking: 50 years' observations on male British doctors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16920470" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12920699" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Environmental tobacco smoke and ischemic heart disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32679883" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Light Cigarette Smoking Increases Risk of All-Cause and Cause-Specific Mortality: Findings from the NHIS Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12920698" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Epidemiology of smoking-induced cardiovascular disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9440661" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1267863" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Cigarette smoking and atherosclerosis in autopsied men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9614255" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10407501" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Smoking and atherosclerosis in youth.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7585737" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Relationship of cigarette smoking to the severity of coronary and thoracic aortic atherosclerosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8203995" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Active and passive smoking are associated with increased carotid wall thickness. The Atherosclerosis Risk in Communities Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10362820" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Effect of cigar smoking on the risk of cardiovascular disease, chronic obstructive pulmonary disease, and cancer in men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10665889" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Cigar smoking and death from coronary heart disease in a prospective study of US men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20952559" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Health consequences of pipe versus cigarette smoking.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6702862" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Epidemiology of coronary heart disease: the Framingham study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15817606" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15451758" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Smokeless tobacco and cardiovascular risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10577570" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Smokeless tobacco as a possible risk factor for myocardial infarction: a population-based study in middle-aged men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24958793" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Discontinuation of smokeless tobacco and mortality risk after myocardial infarction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8129055" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30853474" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Association Between E-Cigarette Use and Cardiovascular Disease Among Never and Current Combustible-Cigarette Smokers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22022776" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Vascular pathology from smoking: look at the microcirculation!
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2496857" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1349365" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Insulin resistance and cigarette smoking.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12651055" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Insulin resistance and compensatory hyperinsulinemia: the key player between cigarette smoking and cardiovascular disease?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9286935" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Association between cigarette smoking and lipid peroxidation in a controlled feeding study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8641023" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8759254" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Enhanced modifications of low-density lipoproteins (LDL) by endothelial cells from smokers: a possible mechanism of smoking-related atherosclerosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9610530" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Passive smoking induces atherogenic changes in low-density lipoprotein.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/950972" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3948369" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Smoking-induced coronary vasoconstriction in patients with atherosclerotic coronary artery disease: evidence for adrenergically mediated alterations in coronary artery tone.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9714109" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Cigarette smoking increases sympathetic outflow in humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10086962" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3565227" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10093968" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Platelet spontaneous aggregation in platelet-rich plasma is increased in habitual smokers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10931797" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Smoking increases tissue factor expression in atherosclerotic plaques: implications for plaque thrombogenicity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11601680" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Cigarette smoking and hypertension influence nitric oxide release and plasma levels of adhesion molecules.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12779299" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11988205" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Relation between markers of systemic vascular inflammation and smoking in women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3297389" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8994413" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Unfavorable effect of smoking on the elastic properties of the human aorta.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8222109" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11602492" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Dysfunctional endothelial nitric oxide biosynthesis in healthy smokers with impaired endothelium-dependent vasodilatation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9525552" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Does passive smoking impair endothelium-dependent coronary artery dilation in women?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8531969" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10982536" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20236788" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8890810" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Deficiency in nitric oxide bioactivity in epicardial coronary arteries of cigarette smokers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8989117" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Long-term smoking impairs platelet-derived nitric oxide release.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21315354" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Effects of smoking on coronary microcirculatory function: a twin study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10194193" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Chronic exposure to nicotine alters endothelium-dependent arteriolar dilatation: effect of superoxide dismutase.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7996418" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Chronic nicotine administration does not affect peripheral vascular reactivity in the rat.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11502707" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Nicotine does not influence arterial lipid deposits in rabbits exposed to second-hand smoke.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11788216" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Contribution of nicotine to acute endothelial dysfunction in long-term smokers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9762395" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : [Relationship between tobacco smoke exposure and the concentrations of carboxyhemoglobin and hemoglobin].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11704374" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Cardiovascular effects of carbon monoxide and cigarette smoking.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2682242" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Short-term effects of carbon monoxide exposure on the exercise performance of subjects with coronary artery disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4846640" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Effect of cigarette smoking and breathing carbon monoxide on cardiovascular hemodynamics in anginal patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8419024" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1555269" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7594035" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9113930" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Coronary risk factors and plaque morphology in men with coronary disease who died suddenly.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8352177" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Effect of cigarette smoking on coronary patency after thrombolytic therapy for myocardial infarction. TEAM-2 Investigators. Second Multicenter Thrombolytic Trials of Eminase in Acute Myocardial Infarction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8917265" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Smoking and prognosis after acute myocardial infarction in the thrombolytic era (Israeli Thrombolytic National Survey).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9398109" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Clinical implications of cigarette smoking in acute myocardial infarction: acute angiographic findings and long-term prognosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15006939" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Paradoxical effect of smoking in the Spanish population with acute myocardial infarction or unstable angina: results of the ARIAM Register.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8636551" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Influence of cigarette smoking on rate of reopening of the infarct-related coronary artery after myocardial infarction: a multivariate analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25790882" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Smoking is associated with adverse clinical outcomes in patients undergoing revascularization with PCI or CABG: the SYNTAX trial at 5-year follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11275926" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Effect of smoking status and abciximab use on outcome after percutaneous coronary revascularization: Pooled analysis from EPIC, EPILOG, and EPISTENT.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7119652" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : A randomised controlled trial of anti-smoking advice: 10-year results.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7050440" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6118715" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23108571" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Myocardial infarction and sudden cardiac death in Olmsted County, Minnesota, before and after smoke-free workplace laws.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31429895" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Association of Smoking Cessation With Subsequent Risk of Cardiovascular Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17296646" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24399557" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Smoking prevalence and cigarette consumption in 187 countries, 1980-2012.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19778665" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Cardiovascular effect of bans on smoking in public places: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17482249" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : The impact of a smoking ban on hospital admissions for coronary heart disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12837716" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3185646" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease. Results from the CASS registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29735485" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Longitudinal Associations of Smoke-Free Policies and Incident Cardiovascular Disease: CARDIA Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26307130" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Association of Smoking Status With Angina and Health-Related Quality of Life After Acute Myocardial Infarction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10987614" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : Smoking cessation reduces mortality after coronary artery bypass surgery: a 20-year follow-up study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9052653" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8417241" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Smoking cessation and decreased risk of stroke in women.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
